The synthesis of a group of thiohydantoins and thiobarbiturates derived from 2-N-arylthiopyridocarbonyl-3,5-dichlorobenzo[b]thiophene is described. The structures of the new compounds are supported by IR, 1 H-NMR and mass spectral data. These compounds were tested in vitro for their antimicrobial activities.
INTRODUCTION
Attempts have been made to modify the structure of thiohydantoin molecules by introducing carrier molecules during drug design with the view of reducing their toxicity. There has been considerable interest in the thiohydantoin ring system, both with regards to heterocyclic chemistry and the pharmacological activities of several of its derivatives. Thiohydantoin derivatives have been found to possess potential biological and medicinal activities, such as antiviral, 1 antifungal 2,3 and anticonvulsant. 4 Thioxopyrimidine derivatives with significant therapeutic importance have drawn our attention. The aim was to develop a facile and convenient route to new deriatives of these molecules in synthetically useful yields. The increasing potency of thioxopyrimidine derivatives have been explored for the development of pharmaceutically important molecules with specific biological activities, such as antiparkinsonian, 5 antiviral, 6 anti-inflammatory and CNS depressant, 7 as well as antimicrobial 8 and anticonvulsant. 9 The structures of the synthesized compounds were assigned on the basis of elemental analyses, FTIR, 1 H-NMR and mass spectral data. The compounds were screened for their in vitro antimicrobial activity.
EXPERIMENTAL
Thin layer chromatography was used to monitor the reactions and the purity of the synthesized compounds. The melting points were determined in open capillary tubes and are uncorrected. IR spectra
thiophene-2-carboxamide (0.1 mol) was dissolved in the minimum amount of pyridine. To this solution, chloroacetic acid (0.94 g, 0.1 mol) and 15 ml of a mixture of ethanol and dioxane (1:1) was added. The resulting mixture was refluxed for 12 h, cooled and the mixture was filtered, concentrated under reduced pressure and the residue crystallized from ethanol. Compound 2i. Yield 56 %, m.p. 140 ºC. Anal. Calcd. for C 19 H 12 N 2 O 3 S 2 Cl 2 : C, 50.55; H, 2.66; N, 6.21 % Found: C. 50,51; H, 2.64; N, 6.20 %. n max cm -1 3050 (CH-CH); 2850 (-CH 3 ), 1681 (C=O, amide), 1180 (C=S), 779 (C-Cl), 713 (C-S-C). d ppm 3.82 (s, 3H, -OCH 3 ), 3.98 (s, -CH 2 ), 6.09-7.95 (m, 7H, Ar-H). The mass spectra of the compound exhibited a molecular ion peak at m/z 452. The other compounds (2a-l) were prepared in a similar manner. Their physical data are given in Tables I and II. Preparation of 3-aryl-1-[(3,5- 
thiophene-2-carboxamide (0.01 mol) and malonic acid (2.6 g, 0.01 mol) in acetyl chloride (15 ml) were refluxed for 6 h on a steam bath. After cooling, the mixture was filtered, concentrated under reduced pressure and the residue crystallized from ethanol. The other compounds (3a-l) were prepared in a similar manner. Their physical data are displayed in Tables I and II. 
Antimicrobial activity
The antimicrobial activity was assayed using the cup-plate agar diffusion method 10 by measuring the zone of inhibition in mm. All the compounds were screened in vitro for their antimicrobial activity against a variety of bacterial strains, that is Bacillus megaterium, Proteus vulgaris, Escherichia coli, Staphylococcus aureus and the fungus Aspergillus niger at 40 mg/ml concentration. Standard drugs like amoxycillin, Benzylpenicillin, ciprofloxacin, erythromycin and griseofulvin were used for comparison purposes (Table III) . It can be seen that compounds 1c, 1e, 2a, 2h, 3a, 3c showed good activity against E. coli, compounds 1c, 2a, 2d, 3a, 3h were active against P. vulgaris, while compounds 1e, 1f, 1k, 2c, 3a, 3h were found to have moderate activity against B. megaterium. Compounds 1a, 1e, 1d, 3g were active against S. aureus and compounds 1a, 2a, 2k, 2l, 3k active against A. niger.
